All Pharma News
price-trendAsk Us
Sobi bets $250M cash, about $1B in milestones for rights to a C3 therapy

Sobi bets $250M cash, about $1B in milestones for rights to a C3 therapy
N.DeFeudis ENDPTS
28 Oct 2020
Share Share
Novimmune unit nabs Takeda milestone payment for hemophilia work

Novimmune unit nabs Takeda milestone payment for hemophilia work
Ben Adams FIERCE BIOTECH
14 Feb 2020
Share Share
Sobi buys rare-disease drug emapalumab, zooms in on hematology and immunology

Sobi buys rare-disease drug emapalumab, zooms in on hematology and immunology
REUTERS
13 Jun 2019
Share Share
Sobi Acquires Emapalumab and Related Assets

Sobi Acquires Emapalumab and Related Assets
PR NEWSWIRE
12 Jun 2019
Share Share
Sobi to buy Novimmune R&D assets, lay off 90 staff

Sobi to buy Novimmune R&D assets, lay off 90 staff
Nick P. Taylor FIERCE BIOTECH
12 Jun 2019
Share Share